Emergent BioSolutions
EBS
#7546
Rank
C$0.57 B
Marketcap
C$11.08
Share price
-0.86%
Change (1 day)
18.31%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): C$0.23 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are C$0.75 Billion. In 2024 the company made an earning of -C$98.8 Million, an increase over its 2023 earnings that were of -C$0.89 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.23 B-337.55%
2024 -C$98.8 Million-88.82%
2023 -C$0.89 Billion242.73%
2022 -C$0.26 Billion-153.8%
2021 C$0.47 B-20.43%
2020 C$0.60 B278.02%
2019 C$0.15 B27.11%
2018 C$0.12 B-27.12%
2017 C$0.17 B17.21%
2016 C$0.14 B0.45%
2015 C$0.14 B73.51%
2014 C$84.23 M41.36%
2013 C$59.59 M35.2%
2012 C$44.07 M0.4%
2011 C$43.9 M-56.46%
2010 C$0.10 B76.73%
2009 C$57.04 M32.94%
2008 C$42.91 M-5.62%
2007 C$45.47 M
2005 C$65.83 M269.89%
2004 C$17.79 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.55 B 6,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.07 B 7,856.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.75 B 5,956.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-C$17 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
C$0.12 B-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.4 Billion-273.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.12 B 1,273.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel